• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白激酶C与特定血管疾病中的内皮功能障碍

Protein kinase C and endothelial dysfunction in select vascular diseases.

作者信息

Kant Shawn, Feng Jun

机构信息

Cardiothoracic Surgery Research Laboratory, Department of Medicine, Rhode Island Hospital, Brown University Health, Providence, RI, United States.

Department of Surgery, Heart Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, United States.

出版信息

Front Cardiovasc Med. 2025 Aug 25;12:1618343. doi: 10.3389/fcvm.2025.1618343. eCollection 2025.

DOI:10.3389/fcvm.2025.1618343
PMID:40926896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12414950/
Abstract

Protein kinases have crucial roles in intracellular signal transduction pathways that affect a wide range of biochemical processes, including apoptosis, metabolism, proliferation, and protein synthesis. Vascular endothelial cells are important regulators of vasomotor tone, tissue/organ perfusion, and inflammation. Since its discovery in the late 1970s, a growing body of literature implicates protein kinase C (PKC) in pathways involving angiogenesis, endothelial permeability, microvascular tone, and endothelial activation. Hence the objective of this review, to characterize the role of PKC in vascular endothelial cells. After discussing the basic principles of PKC structure and function, the focus shifts to abnormal PKC activity driving endothelial dysfunction in three major pathologies whose hallmark is significant vascular disease: diabetes mellitus, hypoxia/ischemia-reperfusion injury, and hypertension. Themes addressed include endothelial cell cycle derangement, endothelial oxidative stress, endothelial activation/inflammation, and impaired endothelial barrier integrity. Achieving a comprehensive understanding of endothelial cell-PKC pathophysiology may lead to development of new therapeutic targets for mitigating morbidity and mortality in these disease states.

摘要

蛋白激酶在细胞内信号转导途径中发挥着关键作用,这些途径影响广泛的生化过程,包括细胞凋亡、代谢、增殖和蛋白质合成。血管内皮细胞是血管舒缩张力、组织/器官灌注和炎症的重要调节因子。自20世纪70年代末被发现以来,越来越多的文献表明蛋白激酶C(PKC)参与了涉及血管生成、内皮通透性、微血管张力和内皮激活的途径。因此,本综述的目的是阐述PKC在血管内皮细胞中的作用。在讨论了PKC结构和功能的基本原理后,重点转向在三种以严重血管疾病为特征的主要病理状态下,异常的PKC活性导致内皮功能障碍:糖尿病、缺氧/缺血-再灌注损伤和高血压。涉及的主题包括内皮细胞周期紊乱、内皮氧化应激、内皮激活/炎症以及内皮屏障完整性受损。全面了解内皮细胞-PKC病理生理学可能会为减轻这些疾病状态下的发病率和死亡率开发新的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e08/12414950/9c1cf390c62f/fcvm-12-1618343-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e08/12414950/91bc944b0f39/fcvm-12-1618343-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e08/12414950/b84d0b3a3f70/fcvm-12-1618343-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e08/12414950/3cc8400c3f2c/fcvm-12-1618343-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e08/12414950/629f3e60d708/fcvm-12-1618343-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e08/12414950/9c1cf390c62f/fcvm-12-1618343-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e08/12414950/91bc944b0f39/fcvm-12-1618343-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e08/12414950/b84d0b3a3f70/fcvm-12-1618343-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e08/12414950/3cc8400c3f2c/fcvm-12-1618343-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e08/12414950/629f3e60d708/fcvm-12-1618343-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e08/12414950/9c1cf390c62f/fcvm-12-1618343-g005.jpg

相似文献

1
Protein kinase C and endothelial dysfunction in select vascular diseases.蛋白激酶C与特定血管疾病中的内皮功能障碍
Front Cardiovasc Med. 2025 Aug 25;12:1618343. doi: 10.3389/fcvm.2025.1618343. eCollection 2025.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Review of the Role of TRAF7 in Brain Endothelial Integrity and Cerebrovascular Aging.TRAF7在脑内皮完整性和脑血管衰老中的作用综述。
Life (Basel). 2025 Aug 12;15(8):1280. doi: 10.3390/life15081280.
4
Luminal Vascular Dysfunction Drives Rapid Blood Brain Barrier Injury in Hyperglycemic Stroke: Key Roles for Luminal Glycocalyx and Complement.管腔血管功能障碍促使高血糖性卒中时血脑屏障快速损伤:管腔糖萼和补体的关键作用
bioRxiv. 2025 Jun 28:2025.06.26.661858. doi: 10.1101/2025.06.26.661858.
5
Downregulation of LATS1/2 Drives Endothelial Senescence-Associated Stemness (SAS) and Atherothrombotic Lesion Formation.LATS1/2的下调驱动内皮细胞衰老相关干性(SAS)和动脉粥样血栓形成病变的形成。
bioRxiv. 2025 Jun 21:2025.06.19.660635. doi: 10.1101/2025.06.19.660635.
6
Clonal hematopoiesis of indeterminate potential (CHIP) in cerebromicrovascular aging: implications for vascular contributions to cognitive impairment and dementia (VCID).脑微血管衰老中的不确定潜能克隆性造血(CHIP):对血管性认知障碍和痴呆(VCID)的影响
Geroscience. 2025 Apr 11. doi: 10.1007/s11357-025-01654-1.
7
Relationship Between Pituitary Gland and Stem Cell in the Aspect of Hormone Production and Disease Prevention: A Narrative Review.垂体与干细胞在激素产生和疾病预防方面的关系:一篇叙述性综述
Endocr Metab Immune Disord Drug Targets. 2025 Jan 13. doi: 10.2174/0118715303314551241031093717.
8
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
9
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and economic analysis.抗血管内皮生长因子药物与激光光凝术治疗糖尿病视网膜病变的比较:系统评价与经济分析
Health Technol Assess. 2025 May 7:1-16. doi: 10.3310/KRWP1264.
10
The alarmin, interleukin-33, increases vascular tone via extracellular signal regulated kinase-mediated Ca sensitization and endothelial nitric oxide synthase inhibition.警报素白细胞介素-33 通过细胞外信号调节激酶介导的钙敏化和内皮型一氧化氮合酶抑制增加血管张力。
J Physiol. 2024 Nov;602(22):6087-6107. doi: 10.1113/JP286990. Epub 2024 Nov 14.

本文引用的文献

1
Systemic and Cardiac Microvascular Dysfunction in Hypertension.高血压中的全身及心脏微血管功能障碍
Int J Mol Sci. 2024 Dec 11;25(24):13294. doi: 10.3390/ijms252413294.
2
Protein Kinase C-β Inhibition and Survival Signaling after Simulated Cardioplegic Ischemia/Reperfusion in Non-Diabetic and Diabetic Human Coronary Arterial Endothelial Cells.蛋白激酶C-β抑制与非糖尿病和糖尿病患者冠状动脉内皮细胞模拟心脏停搏缺血/再灌注后的生存信号传导
J Am Coll Surg. 2024 Dec 9. doi: 10.1097/XCS.0000000000001248.
3
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets.
缺血再灌注损伤:分子机制与治疗靶点。
Signal Transduct Target Ther. 2024 Jan 8;9(1):12. doi: 10.1038/s41392-023-01688-x.
4
An Update on Protein Kinases as Therapeutic Targets-Part I: Protein Kinase C Activation and Its Role in Cancer and Cardiovascular Diseases.蛋白激酶作为治疗靶点的最新研究进展——第一部分:蛋白激酶 C 的激活及其在癌症和心血管疾病中的作用。
Int J Mol Sci. 2023 Dec 18;24(24):17600. doi: 10.3390/ijms242417600.
5
Acute protein kinase C beta inhibition preserves coronary endothelial function after cardioplegic hypoxia/reoxygenation.急性蛋白激酶Cβ抑制可在心脏停搏缺氧/复氧后保留冠状动脉内皮功能。
JTCVS Open. 2023 Jul 6;15:242-251. doi: 10.1016/j.xjon.2023.06.014. eCollection 2023 Sep.
6
Endostatin Inhibits Blood-Retinal Barrier Breakdown in Diabetic Rats by Increasing the Expression of ICAM-1 and VCAM-1 and Decreasing the Expression of VEGF.内皮抑素通过增加细胞间黏附分子-1(ICAM-1)和血管细胞黏附分子-1(VCAM-1)的表达以及降低血管内皮生长因子(VEGF)的表达来抑制糖尿病大鼠的血视网膜屏障破坏。
Comput Math Methods Med. 2022 Jan 17;2022:5105866. doi: 10.1155/2022/5105866. eCollection 2022.
7
Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols.糖尿病肾病中的氧化应激和炎症:多酚的作用。
Front Immunol. 2023 Jul 21;14:1185317. doi: 10.3389/fimmu.2023.1185317. eCollection 2023.
8
Ginsenoside Rg1 attenuates diabetic vascular endothelial dysfunction by inhibiting the calpain-1/ROS/PKC-β axis.人参皂苷 Rg1 通过抑制钙蛋白酶-1/ROS/PKC-β 轴减轻糖尿病血管内皮功能障碍。
Life Sci. 2023 Sep 15;329:121972. doi: 10.1016/j.lfs.2023.121972. Epub 2023 Jul 22.
9
Hyperoside ameliorates cerebral ischaemic-reperfusion injury by opening the TRPV4 channel through the IP-PKC signalling pathway.金丝桃苷通过 IP-PKC 信号通路开放 TRPV4 通道减轻脑缺血再灌注损伤。
Pharm Biol. 2023 Dec;61(1):1000-1012. doi: 10.1080/13880209.2023.2228379.
10
Prevalence of Diabetic Retinopathy in the US in 2021.2021 年美国糖尿病视网膜病变的患病率。
JAMA Ophthalmol. 2023 Aug 1;141(8):747-754. doi: 10.1001/jamaophthalmol.2023.2289.